PHXM

PHAXIAM Therapeutics S.A.. American Depositary Shares

Delisted

PHXM was delisted on the 8th of March, 2024.

5 hedge funds and large institutions have $5.97M invested in PHAXIAM Therapeutics S.A.. American Depositary Shares in 2022 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, 3 reducing their positions, and 4 closing their positions.

Holders
5
Holders Change
-4
Holders Change %
-44.44%
% of All Funds
0.08%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
1
Reduced
3
Closed
4
Calls
$750K
Puts
Net Calls
+$750K
Net Calls Change
-$262K
Name Market Value Shares Shares
Change
Shares
Change %
AC
1
Armistice Capital
New York
$3.4M 1,944,075 -793,497 -29%
BI
2
BVF Inc
California
$2.39M 1,314,656
Jane Street
3
Jane Street
New York
$93K 48,673 +3,034 +7%
Citadel Advisors
4
Citadel Advisors
Florida
$62K 33,973 -39,352 -54%
Group One Trading
5
Group One Trading
Illinois
$19K 10,415 -200 -2%
Susquehanna International Group
6
Susquehanna International Group
Pennsylvania
-20,711 Closed
CS
7
Credit Suisse
Switzerland
-16,900 Closed
UBS Group
8
UBS Group
Switzerland
-3,583 Closed
TRCT
9
Tower Research Capital (TRC)
New York
-321 Closed
CFGS
10
Concourse Financial Group Securities
Alabama